CLASS II Device recall · Reported 4 Sep 2019 · FDA Enforcement Report

GlidePath Long-Term Hemodialysis Catheter with Preloaded stylet recalled

Bard Peripheral Vascular is recalling GlidePath Long-Term Hemodialysis Catheter with Preloaded stylet, distributed in 52 states. The recall was initiated on 31 May 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # REDN1398 Exp. 3/31/2020
Quantity recalled39 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2394-2019
FDA event ID
83337
Recalling firm
Bard Peripheral Vascular, Tempe, AZ
Classification
Class II
Status
Terminated
Recall initiated
31 May 2019
FDA classified
26 Aug 2019
Reported
4 Sep 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

31 May 2019Recall initiated by company
26 Aug 2019Classified by FDA+87 days
4 Sep 2019Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The action is being initiated due to complaints received concerning the molded tip of the tunneler breaking or is damaged during the placement procedure of the catheter.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

GlidePath Long-Term Hemodialysis Catheter with Preloaded stylet, REF/Product code:5397350, 14.5F, straight, 35cm length, BARD, UDI: 00801741012334

Where it was distributed

US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA,MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY OUS: Australia, Canada,

AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusetts

Questions about this recall

Is GlidePath Long-Term Hemodialysis Catheter with Preloaded stylet recalled?

Yes. Bard Peripheral Vascular recalled GlidePath Long-Term Hemodialysis Catheter with Preloaded stylet on 31 May 2019. The recall is Class II and its status is Terminated. Recall number Z-2394-2019.

Why was it recalled?

The action is being initiated due to complaints received concerning the molded tip of the tunneler breaking or is damaged during the placement procedure of the catheter.

Which lots are affected?

Lot # REDN1398 Exp. 3/31/2020

Where was it sold?

US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA,MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY OUS: Australia, Canada,

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bard Peripheral Vascular

All 138

Other Heart & Vascular Devices recalls

All 6,190